- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gastric or Gastroesophageal Junction Adenocarcinoma in United Kingdom
Total 707 results
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingGastric Cancer | Gastric Adenocarcinoma | Esophagogastric JunctionUnited States
-
National Cancer Institute (NCI)Active, not recruitingGastric Cancer | Gastric Adenocarcinoma | Peritoneal Carcinomatosis | Esophagogastric JunctionUnited States
-
Leap Therapeutics, Inc.BeiGeneActive, not recruitingGastric Cancer | Gastric Adenocarcinoma | GastroEsophageal CancerUnited States, Korea, Republic of, Germany
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Metastatic Pancreatic Carcinoma | Refractory Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer... and other conditionsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedStomach Cancer | Gastric Cancer | Gastro-esophageal Junction CancerUnited States
-
Bristol-Myers SquibbWithdrawnStomach Cancer | Gastric Cancer | Cancer of the Stomach | Gastroesophageal JunctionBrazil, Italy, United States, Argentina, Chile, Germany, Spain, Australia, Canada, Portugal, Mexico, Romania, Colombia, Puerto Rico
-
PrecirixTerminatedAdvanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care TreatmentUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingEsophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle UniversityUnknownGastric Adenocarcinoma | Esophageal AdenocarcinomaUnited Kingdom
-
Jazz PharmaceuticalsBeiGene, Ltd.RecruitingGastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric NeoplasmsKorea, Republic of, Belgium, Japan, China, Netherlands, Spain, Germany, United Kingdom, Malaysia, Portugal, France, Italy, Australia, Taiwan, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Poland, Brazil, ... and more
-
Taiho Oncology, Inc.TerminatedMetastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal JunctionBelgium, Spain, United States, Italy, Estonia, Russian Federation, Bulgaria, Hungary, Croatia, Israel, Mexico, Poland, Portugal, Romania, South Africa, Ukraine, United Kingdom, Brazil, Germany, Argentina
-
University of Colorado, DenverNational Cancer Institute (NCI)Withdrawn
-
Massachusetts General HospitalIpsenRecruitingEsophagogastric Cancer | Gastroesophageal Junction AdenocarcinomaUnited States
-
Institute of Child HealthCompletedGastro-Oesophageal RefluxUnited Kingdom
-
Eli Lilly and CompanyCompletedRenal Cell Carcinoma | Non-Small Cell Lung Cancer | Gastric Adenocarcinoma | Advanced Cancer | Hepatocellular Cancer | Gastroesophageal Junction AdenocarcinomaUnited States
-
Imperial College LondonCompletedGastro-oesophageal Reflux DiseaseUnited Kingdom
-
Case Comprehensive Cancer CenterTerminatedAdenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the EsophagusUnited States
-
Royal Marsden NHS Foundation TrustCompletedSarcoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)TerminatedAdenocarcinoma of the Gastroesophageal Junction | Stage IIIA Esophageal Adenocarcinoma | Stage IIIB Esophageal Adenocarcinoma | Stage IIIC Esophageal Adenocarcinoma | Stage IIB Esophageal AdenocarcinomaUnited States
-
NorgineCompletedAcid Reflux | Gastro Oesophageal Reflux DiseaseUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditionsUnited States
-
Leap Therapeutics, Inc.AvailableGastric Cancer | Ovarian Cancer | Gastric Adenocarcinoma | Carcinosarcoma | Endometrial Cancer | Adenocarcinoma of the Gastroesophageal Junction | GastroEsophageal Cancer | Uterine Cancer | Esophageal Neoplasm | Squamous Cell CarcinomaUnited States
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
University of California, IrvineSanofi-SynthelaboTerminatedGastric Carcinoma | Gastroesophageal Junction CarcinomaUnited States
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; Curis, Inc.RecruitingStomach Cancer | Gastric Cancer | Esophageal Cancer | Gastroesophageal Junction Cancer | Esophagus CancerUnited States
-
King's College Hospital NHS TrustCompletedNear Focus NBI-Driven Artificial Intelligence for the Diagnosis of Gastro-Oesophageal Reflux DiseaseGastro Esophageal RefluxUnited Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnEsophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Imperial College LondonActive, not recruitingGastric Cancer | Esophagitis | Gastro Esophageal Reflux | Barrett Esophagus | Oesophageal Cancer | GORD | Oesophageal Reflux | Oesophageal CarcinomaUnited Kingdom
-
University of NebraskaNational Cancer Institute (NCI)TerminatedEsophageal Adenocarcinoma | Adenocarcinoma of the Gastroesophageal Junction | Stage IIB Esophageal Cancer | Stage IIA Esophageal CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
AstraZenecaTerminatedGastric Cancer | Gastro-oesophageal Junction CancerBulgaria, Czech Republic, Italy, Korea, Republic of, Spain, United Kingdom, Hungary, Romania, Ukraine, Belgium, Canada, Germany, Taiwan, India, Japan, France
-
Neovii BiotechCompletedGastric Cancer | Gastric AdenocarcinomaAustria, Spain, United Kingdom, Germany
-
Memorial Sloan Kettering Cancer CenterBayerCompletedEsophageal Cancer | Gastroesophageal Junction CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); AmgenCompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric Cancer | Stage IIB Gastric Cancer | Stage IIIA Esophageal Adenocarcinoma | Stage IIIB Esophageal Adenocarcinoma | Stage IIIC Esophageal AdenocarcinomaUnited States
-
Brown UniversityAstraZenecaRecruitingEsophageal Cancer | Esophageal Adenocarcinoma | HER-2 Protein Overexpression | Gastroesophageal-junction CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedGastroesophageal Junction Adenocarcinoma | Stage IB Esophageal Adenocarcinoma AJCC v7 | Stage II Esophageal Adenocarcinoma AJCC v7 | Stage IIA Esophageal Adenocarcinoma AJCC v7 | Stage IIB Esophageal Adenocarcinoma AJCC v7 | Stage IIIA Esophageal Adenocarcinoma AJCC v7 | Stage IIIB Esophageal...United States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States, Puerto Rico
-
The Methodist Hospital Research InstituteCompletedEsophageal or Gastric Perforations | Esophageal or Gastric LeaksUnited States
-
National Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Adenocarcinoma of the Gastroesophageal Junction | Recurrent Breast Cancer | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, IrvineNatera, Inc.Not yet recruitingGastroesophageal AdenocarcinomaUnited States
-
ImmunoGen, Inc.WithdrawnStomach Neoplasms | Metastatic or Locally Advanced Gastric Cancer | Metastatic or Local Advanced GE Junction CancerUnited States
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbActive, not recruiting
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) and other collaboratorsRecruitingGastric Cancer | Colorectal Cancer | NSCLC | Head and Neck Squamous Cell Carcinoma | HNSCC | Advanced/Metastatic Solid Tumors | Gastroesophageal-junction CancerUnited States, Spain, Belgium, France, Netherlands, United Kingdom
-
Astellas Pharma Global Development, Inc.RecruitingGastric Cancer | Pharmacokinetics of Zolbetuximab | Gastro-esophageal Junction (GEJ) Cancer | Pharmacokinetics of Oxaliplatin | Pharmacokinetics of Fluorouracil Bolus (5-FU)United States, Japan, Italy, Korea, Republic of, Taiwan, France
-
University of Southern CaliforniaNational Cancer Institute (NCI); New York UniversityCompletedGastric Cancer | Gastric AdenocarcinomaUnited States
-
BioNTech SETerminatedGastric Cancer | Pancreatic Cancer | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Canada